UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000040118
Receipt No. R000045743
Scientific Title Effects of sleep deprivation on the wake state instability
Date of disclosure of the study information 2020/04/09
Last modified on 2020/04/09

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Effects of sleep deprivation on the wake state instability
Acronym Effects of sleep deprivation on the wake state instability
Scientific Title Effects of sleep deprivation on the wake state instability
Scientific Title:Acronym Effects of sleep deprivation on the wake state instability
Region
Japan

Condition
Condition Healthy subject
Classification by specialty
Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To understand the effects of sleep deprivation on the wake state instability
Basic objectives2 Others
Basic objectives -Others To understand the effects of sleep deprivation on the cognitive performance
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes 1. Psychomotor vigilance task
2. Time production task
Key secondary outcomes 1. Wakefulness
2. Subjective sleepiness / fatigue
3. Sleep architecture during sleep and sleep deprivation

Base
Study type Interventional

Study design
Basic design Cross-over
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control No treatment
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Prevention
Type of intervention
Behavior,custom
Interventions/Control_1 A. normal sleep
B. sleep deprivation
The order of laboratory is (A, B).
Interventions/Control_2 A. normal sleep
B. sleep deprivation
The order of laboratory is (B, A).
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
60 years-old >
Gender Male and Female
Key inclusion criteria 1. Those who do not have difficulty in filling out Japanese explanatory documents, consent forms, and survey forms
2. Those who can stay in the examination room on the 5th floor of the Innovation Medical Research Institute, University of Tsukuba
3. Those who have never been treated for mental illness or sleep disorder
4. Those who currently have no symptoms to be treated
5. Those who can visit the lab or return home by walking, public transportation, or pick-up by others
Driving by themselves (including bicycles) after the experiment is not allowed.
Key exclusion criteria . Those who are living irregular lives (Regular life: 21: 00 ~ 1: 00 going to bed, getting up from 6: 00 ~ 9: 00, sleeping 7 ~ 9 hours)
2. Thin (below BMI18.5) or obese (over BMI25) physique
3. Those who worked night shift (after 22:00) within the last 3 months
4. Those who have traveled to a country with a time difference of 3 hours or more within the last 3 months
5. Those who drink alcohol regularly (at least 40 g of pure alcohol [approximate: 2 cans of beer] twice a week or more)
6. Those who have a smoking habit
7. Those who have a daily caffeine intake of 300 mg or more (approximate: 5 cups of 150 mL coffee)
8. Those who may fall under 1. -7. above during the experiment period
9. Extreme eveningness type or extreme morningness type (Morningness-Eveningness Questionnaire score 30 points or less or 70 points or above)
10. Those whose Pittsburgh Sleep Questionnaire scores more than 5.5
11. Those whose Epworth sleepiness scale score of 11 or higher
12. Those who have a disease that may change suddenly or have a history
13. Those who have claustrophobic
14. Those who are pregnant or may be pregnant
15. Those who are under lactation
16. Those who are judged by the investigator to be inappropriate
Target sample size 30

Research contact person
Name of lead principal investigator
1st name Takashi
Middle name
Last name Abe
Organization University of Tsukuba
Division name International Institute for Integrative Sleep Medicine (WPI-IIIS)
Zip code 305-0821
Address Innovation Medical Research Institute 502, 1-2 Kasuga, Tsukuba, Ibaraki
TEL 029-859-1858
Email abe.takashi.gp@u.tsukuba.ac.jp

Public contact
Name of contact person
1st name Takashi
Middle name
Last name Abe
Organization University of Tsukuba
Division name International Institute for Integrative Sleep Medicine (WPI-IIIS)
Zip code 305-0821
Address Innovation Medical Research Institute 502, 1-2 Kasuga, Tsukuba, Ibaraki
TEL 029-859-1858
Homepage URL
Email abe.takashi.gp@u.tsukuba.ac.jp

Sponsor
Institute International Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba
Institute
Department

Funding Source
Organization Japan Society for the Promotion of Science
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Clinical Research Ethics Review Committee, University of Tsukuba Hospital
Address 2-1-1 AmakuboTsukuba, Ibaraki 305-0005
Tel 029-853-3914
Email jisedai@md.tsukuba.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 筑波大学国際統合睡眠医科学研究機構 International Institute for Integrative Sleep Medicine, University of Tsukuba (WPI-IIIS)

Other administrative information
Date of disclosure of the study information
2020 Year 04 Month 09 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2019 Year 12 Month 13 Day
Date of IRB
Anticipated trial start date
2020 Year 05 Month 11 Day
Last follow-up date
2020 Year 09 Month 30 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2020 Year 04 Month 09 Day
Last modified on
2020 Year 04 Month 09 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045743

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.